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Synthesis of highly substituted 3-ﬂuorofurans is reported. The sequence began with preparation of tert-
butyldimethylsilyl alk-1-en-3-yn-1-yl ethers from 1,4-disubstituted alk-3-yn-1-ones. Subsequent
ﬂuorination of alkenynyl silyl ethers with Selectﬂuor gave 2-ﬂuoroalk-3-yn-1-ones in almost quantitative
yield. Subsequent 5-endo-dig cyclizations using chlorotriphenylphosphine gold(I)/silver
triﬂuoromethanesulfonate (5/5 mol%), N-bromo- or N-iodosuccinimide and gold(I) chloride/zinc bromide
(5/20 mol%), all at room temperature, provided a facile method for the generation of substituted 3-ﬂuoro-,
3-bromo-4-ﬂuoro-, and 3-ﬂuoro-4-iodofurans in good yields. Also, 2,2-diﬂuoroalk-3-yn-1-ones were
prepared by ﬂuorination of alk-3-yn-1-ones under organocatalytic conditions. The structures of (Z)-tert-
butyldimethylsilyl but-1-en-3-yn-1-yl ether, 3-bromo-4-ﬂuorofuran, and 3-ﬂuoro-4-(phenylethynyl)furan
were conﬁrmed by X-ray crystallography.
Introduction
Active pharmaceutical ingredients incorporating the ﬂuorine atom
have found wide applications in the ﬁeld of medicinal chem-
istry.1,2 Currently, ﬂuorine-containing compounds are leading in
the list of best-selling drugs.3 In fact, ﬂuorofuran or perﬂuoroalk-
ylfuran fragments have already been embedded within structures
possessing interesting pharmacological properties.4,5 Since the
furan ring constitutes a submotif of medicinal interest,6 corre-
sponding ﬂuorinated molecules are highly sought after building
blocks. Thus, upon considering the pharmaceutical potential, as
well as the limitations of available synthetic methods for 3-ﬂuoro-
furans, we decided to pursue the development of their synthesis.
Halofurans are important derivatives, extensively utilized for
the preparation of acyclic, carbocylic, and heterocyclic com-
pounds. In addition, halofurans provide an opportunity for
further functionalization. In particular, iodo-, bromo-, and also
recently chlorofurans have been useful substrates for a variety of
bond-forming reactions.7–11 In general, approaches to the syn-
thesis of β-halofurans can be divided into substitution reactions
on the furan core and the construction of a furan ring starting
from acyclic precursors.12,13 The later centers on cycloisomeriza-
tion or cyclocondensation reactions and includes halogenation/
cyclizations, and cyclizations of precursors that contain already
introduced halogens. Electrophilic cyclization reactions are par-
ticularly attractive since they provide versatile access to different
halofurans by treatment of the same starting material with differ-
ent halogens.14,15 Usually the electrophile acts as both the cycli-
zation initiator and a halogen donor, thus fostering material
economy. However, ﬂuorine, due to its limited electrophilic char-
acter, is not effective in electrophilic cyclizations.16 So far, pre-
parative access to 3-ﬂuorofurans includes only a few speciﬁc
methods; the syntheses usually encompass aggressive conditions
or poor yields.12
Only scarce reports provide a preparative route to β,β′-
ﬂuorohalofurans, which offer an opportunity for further functio-
nalization of ﬂuorofurans. The iodocyclization of gem-diﬂuoroho-
mopropargyl alcohols (2,2-diﬂuoroalk-3-yn-1-ols) can be induced
by iodine monochloride in the presence of a base and microwave
irradiation.7 Subsequent silica gel aromatization of 3,3-diﬂuoro-4-
iodo-2,3-dihydrofurans leads to the 3-ﬂuoro-4-iodofurans. Only
one example of 3-bromo-4-ﬂuorofuran, prepared by a sequential
lithiation/bromination reaction of 3-ﬂuoro-2,5-diphenylfuran, has
been reported with undisclosed preparative yield.17
In order to access a family of β-ﬂuorofurans (1), we elected to
introduce ﬂuorine into an acyclic skeleton and to use 2-ﬂuoro-
alk-3-yn-1-ones (2) as a versatile cyclization starting material
(Scheme 1).18,19 Fluoroalkynone 2 contains one less ﬂuorine
Scheme 1 Retrosynthetic approach to β-ﬂuorofurans.
†Electronic supplementary information (ESI) available: 1H, 13C, and 19F
NMR spectra for diﬂuorobutynones 4, silyl ethers 6, and ﬂuorofurans
10–13. CCDC reference numbers 826570, 826571 and 827011. For ESI
and crystallographic data in CIF or other electronic format see DOI:
10.1039/c1ob06693e
aDepartment of Chemistry, Oakland University, 2200 N. Squirrel Rd,
Rochester, MI 48309-4477, USA. E-mail: dembinsk@oakland.edu
bEastern Illinois University, 600 Lincoln Avenue, Charleston, IL 61920-
3099, USA
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 2395–2408 | 2395
D
ow
nl
oa
de
d 
by
 E
BS
CO
 o
n 
02
 N
ov
em
be
r 2
01
2
Pu
bl
ish
ed
 o
n 
20
 Ja
nu
ar
y 
20
12
 o
n 
ht
tp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C1
OB
066
93E
View Online
atom in comparison to the gem-diﬂuorohomopropargyl alcohol,
hence it should prove to be more versatile and reactive towards
cyclization reactions. This substrate would generate a convergent
synthetic opportunity to also obtain β,β′-ﬂuorohalofurans.
Thus far, the preparations of 2-ﬂuoroalk-3-yn-1-ones 2 have
been reported via the oxidation of 2-ﬂuoroalk-3-yn-1-ols, which
are accessed by a low-yielding ring opening of an oxirane pre-
cursor by a ﬂuoride anion,20 or via a zinc- or indium(III) chlor-
ide-catalyzed reaction of ﬂuoropropargyl halides with carbonyl
compounds.21,22 Therefore, we sought to secure more convenient
access to ﬂuoroalkynones 2 as key starting materials, establish
their cyclization reactions at mild conditions despite the thwart-
ing inﬂuence of ﬂuorine atom on their reactivity, and ﬁnally,
functionalize the iododerivatives to trisubstituted 3-ﬂuorofurans.
The current results extend our exploration of cycloisomerization
and electrophilic halocyclization reactions.10,23–26 Here we report
our attempts towards the syntheses of a family of substituted
β-ﬂuorofurans 1 from alk-3-yn-1-ones 3.
Results and discussion
We sought to develop a more effective ﬂuorofuran synthesis in
terms of halogen atom economy. To introduce a ﬂuorine atom at
the relatively late stage of the synthesis we envisioned direct
ﬂuorination of alk-3-yn-1-ones 3 in a joint α-position to the
alkyne and ketone.27 Monoﬂuorination procedures for regular
ketones at their α-carbon are known.28–30 However, a reaction of
alkynone 3a with NFSI (1 equiv), in the presence of the inor-
ganic base (potassium carbonate), leads to isolation of the
diﬂuoro derivative 4a.31 Since monoﬂuorination of regular
ketones can also be accomplished under organocatalytic con-
ditions,32 an analogous approach was investigated. Unfortu-
nately, the reaction of alkynone 3a with Selectﬂuor33 (1.1
equiv), in the presence of L-proline (10 mol%) and molecular
sieves, led again to a mixture of monoﬂuoro and diﬂuoro deriva-
tives 2a and 4a (4.5 : 1 ratio) that were difﬁcult to separate.
Since the α-proton of 2a is more acidic than the one in substrate
3a, the product, in the presence of a base, equilibrates to a com-
petitive enolate.
Considering the popular use of diﬂuoropropargyl moieties in
synthetic34,35 and biological chemistry36 we took the opportunity
to integrate mild organocatalytic conditions into the preparation
of the diﬂuoro derivatives 4. So far, ﬂuoroalkynones 4 have been
prepared starting from chloroﬂuorocarbons via gem-diﬂuoroho-
mopropargyl alcohols.37 When the alkynones 3a,e were reacted
with Selectﬂuor (2.3 equiv) in the presence of L-proline (20 mol
%) and 5 Å molecular sieves (acetonitrile, room temperature),
diﬂuoroalkynones 4a,e were isolated with 63% and 67% yield
(Scheme 2). The convenient access to alkynones 3 include,
among others, oxidation of alkynols 5.38,39
Furthermore, alternative access to ﬂuoroketones 2, in the
absence of a base was pursued. Electrophilic ﬂuorodesilylation
of silyl enol ethers has literature precedence.16,40 However, we
were unable to ﬁnd a general synthesis of alk-1-en-3-yn-1-yl
silyl ethers 6. So far, synthetic methods for silyl ethers (silyloxy
enynes) of type 6 have only been described for individual com-
pounds. Literature reports include the reaction of an alkynyl
oxirane with BuLi in the presence of TMSCl,41 rearrangement of
an α-alkoxy carbene derived from aldehyde and N-amino-2,3-
diphenylaziridine derivative,42 or ring opening of furans.43 The
pathway starting from alkynones 3 via enolization has not yet
been reported.
The conversion of alkynone 3a24a to the corresponding
t-butyldimethylsilyl enol ether 6a and its trimethylsilyl lower
homolog was accomplished using a procedure similar to the lit-
erature protocol for regular silyl ether.44 Since 6a was sufﬁ-
ciently stable for isolation by column chromatography, the
remaining silyl enol ethers 6b–h were then prepared as the
t-butyldimethylsilyl derivatives.
Although some of the solid alkynones 3 can be isolated via
crystallization and stored for months in a refrigerator, frequent
instability of liquids or solutions was encountered. The lack of
an effective and timely puriﬁcation procedure, especially for
compounds 3g and 3h, prompted us to begin the synthesis from
alkynols 5. Since the oxidation of 5 with a Jones reagent is
efﬁcient,38 ketones 3 were used as a crude material in a two step
process (Scheme 3).
The enolate was initially formed via deprotonation of alky-
none 3a with LDA in THF at −78 °C (procedure A, Table 1).
Additional optimization of the preparative procedure was sought.
TMEDA, a bidentate ligand coordinating lithium was added (2
equiv, procedure B), affording the enolate with comparable or
slightly higher yields. The silylation did not proceed with a
higher reaction rate. The substrate with the cyclopropyl alkynyl
group gave a low yield of silyl ether 6b with procedure A (11%,
Table 1, entry 2). Applying conditions B resulted in a complex
reaction mixture without detectable amounts of silyl ether 6b,
presumably due to the sensitivity of the cyclopropyl group
towards the reaction environment. Therefore thermodynamic
conditions (procedure C) for the cyclopropyl-containing sub-
strate were tried. The combination of the cyclopropyl ketone,
DBU (1.1 equiv), TBSCl (1.2 equiv), and NaI (0.2 equiv) in
anhydrous acetonitrile at ambient temperature gave 6b in 60%
yield (two step synthesis starting from 5b, 5 mmol scale). The
substrate with the phenoxymethyl group, derived from glycidol,
was converted to its ether 6h using conditions C as well (55%
yield, Table 1).
Scheme 3 Synthesis of silyl ethers 6. Procedures: A) LDA (1.1 equiv),
THF, −78 °C to rt, 12 h. B) LDA (1.1 equiv), TMEDA (1.2 equiv),
THF, −78 °C to rt, 12 h. C) DBU (1.1 equiv), NaI (0.2 equiv), aceto-
nitrile, rt, 4 h.
Scheme 2 Fluorination of butynones 3a,e.
2396 | Org. Biomol. Chem., 2012, 10, 2395–2408 This journal is © The Royal Society of Chemistry 2012
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The substrate 5g with an ethyl substituent leads to a ketone
with two carbons available for enolization. Under kinetic con-
ditions (procedure A), formation of the conjugated ether 6g was
observed. The ethyl substituted ether 6g was rather unstable;
after a slower silica gel column chromatography a fraction was
collected that was rich in corresponding allenyl ketone.45 Appar-
ently desilylation of silyl ether and isomerization had occurred.
Fast ﬁltration through a plug of deactivated silica gel brought
access to 6g that was still accompanied with a small amount of
allenyl ketone.
The silyl ethers 6a–h were obtained in 52–68% overall yield
(Table 1) after puriﬁcation by column chromatography. The pro-
longed contact of silyl ethers 6 with silica gel was detrimental to
the yield; the optimum preparative scale was established as
6 mmol (> 1 g). On a smaller scale, such as 0.5 mmol, yields
were usually higher since the chromatography procedure can be
completed more rapidly.
After isolation, the predominance of one stereoisomer was
observed. The structural assignments of regular silyl enol ethers
are frequently based upon the chemical shift of vinyl protons in
the 1H NMR spectrum47,48 or, trustworthier, of allylic carbons in
the 13C NMR spectrum.49,50 However, such an assignment may
not necessarily extrapolate into the sp carbons of a triple bond or
ipso carbons of an aryl ring, which, due to low relaxation,
usually require longer acquisition time. Accordingly, we were
not able to observe the relevant CuC signals for the low abun-
dant isomer. Table 2 summarizes the chemical shift trends for
the signals that differentiated both isomers.
Due to lack of stereochemical E/Z assignments for silyloxy
enynes49 an unequivocal conﬁrmation was sought. Fortunately,
slow evaporation of a hexane/ethyl acetate solution of compound
6e gave a single crystal suitable for X-ray analysis. Inspection of
Fig. 1 reveals the molecular structure of the Z-silyl enol ether 6e.
This result is in agreement with the dominant Z stereochemistry
for silyl ethers derived from phenyl-substituted ketones.47
The ﬂuorination reaction simpliﬁed the stereochemical
outcome. Since E and Z stereoisomers presumably produce the
same racemic mixture of 2-ﬂuoroalkynone 2, the mixture of both
stereoisomers was subjected to the reaction. The reaction of 6a
with Selectﬂuor at room temperature gave a monoﬂuoroketones
2a in almost quantitative yield (Scheme 4).23 Fluoroketone 2b
was also characterized by NMR.
Non-ﬂuorinated alkynones 3 can be converted to furans using
zinc, silver, palladium, and other transition metals-containing
catalysts.24a,51 Unfortunately cycloisomerization of 2a with zinc
chloride etherate or silver nitrate was inhibited by the electron
withdrawing effect of ﬂuorine (Table 3, entry 1 and 2). When
ﬂuoroketone 2 was treated with the (PhCN)2PdCl2 (10 mol %),
19
ﬂuorofuran 7a was isolated in 60% yield.
Table 1 Synthesis of silyl ethers 6
Alkynol 5 R R′ Procedure
Yield
6 [%]
E/Z
ratio46
a Ph p-MeC6H4 A 52 16 : 84
B 60 13 : 87
b Ph c-C3H5 A 11 nd
B nda nd
C 60 8 : 92
c p-FC6H4 p-MeC6H4 A 28 26 : 74
B 32 17 : 83
C 52 2 : 98
d p-BrC6H4 p-MeC6H4 A 65 nd
B 62 2 : 98
e p-BrC6H4 p-t-BuC6H4 A 59 nd
B 68 6 : 94
f p-CF3C6H4 p-MeC6H4 B 61 3 : 97
g Et Ph A 68 89 : 11b
h PhOCH2 p-MeC6H4 C 55 22 : 78
nd = not determined. aComplex reaction mixture. b Tentative E/Z
assignment based upon 1H NMR.
Table 2 NMR resonances for silyl ethers isomers 6a
Silyl ether 6 Ratio CvCH major/min CH3Si major/min (CH3)3CSi major/min CvCH major/min CH3Si major/minor
a 87 : 13 5.59/5.38 0.17/0.21 1.03/1.00 91.0/90.4 −3.6/−4.3
b 92 : 8 5.31/5.14 0.13/0.16 1.01/0.97 91.1/90.8 −3.6/−4.3
c 98 : 2 5.52/5.31 0.17/0.21 1.02/0.99 90.8/nd −3.5/nd
d 98 : 2 5.58/5.39 0.18/0.21 1.02/0.99 91.5/90.4 −3.5/nd
e 94 : 6 5.59/5.40 0.19/0.21 1.03/0.99 91.6/nd −3.5/−4.3
f 97 : 3 5.68/5.48 0.19/0.23 1.03/1.00 92.9/nd −3.5/nd
g 89 : 11 4.89/4.93 0.22/na 0.96/na 91.7/91.5 −4.3/−3.6
h 78 : 22 5.32/5.23 0.32/0.17 1.01/0.93 90.9/nd −3.7/−4.4
nd = not detected. na = not assigned. a 1H/13C 400/100 MHz, CDCl3, 22 °C, δ, ppm.
Fig. 1 An ORTEP view of 6e illustrating the atom labeling scheme
and thermal ellipsoids (50% probability level). Selected interatomic dis-
tances (Å): Si1–O1 1.6742(14), O1–C2 1.361(2), C2–C3 1.346(3), C2–
C6 1.477(3), C3–C4 1.421(3), C4–C5 1.209(3), C5–C12 1.435(3). Key
angles (°): Si1–O1–C2 130.81(13), O1–C2–C3 122.16(19), C3–C2–C6
123.12(18), O1–C2–C6 114.60(18), C2–C3–C4 124.92(19), C3–C4–C5
178.2(2), C4–C5–C12 176.3(2).
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 2395–2408 | 2397
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Cationic gold compounds show unique activities toward
alkynes, promoting the nucleophilic addition of a variety of
functional groups inter- and intramolecularly. Heterocycle for-
mation via vinyl-gold type intermediates that can be isolated has
already been established.52 Gold catalysts such as AuCl3, AuCl,
and PPh3AuCl have proved effective in the cyclization reac-
tions.53 Although gold(I) and (III) are both carbophilic, their com-
plexes could differ in selectivity for the same reactant. Au(III)
exhibits a thermodynamic preference for heteroatom coordi-
nation over carbon–carbon multiple bonds (and has a relatively
high oxidative potential), while Au(I) increases the relative
strength of coordination to the carbon-carbon multiple bonds.54
The use of AuCl3 (5 mol%) led to the formation of multiple pro-
ducts (Table 3, entry 4). When AuCl (5 mol%) was combined
with 2a in anhydrous DCM at ambient temperature, the reaction
showed no conversion to the ﬂuorofuran in 2 h, although trace
amounts of other products were observed in the 1H NMR and
19F NMR (Table 3, entry 5). An easy-to-handle (air-stable) and
commercially available triphenylphosphine gold(I) chloride was
selected for investigation. The coordination with triphenylpho-
sphine decreases the Lewis acidity of auric salts, and the triphe-
nylphophine gold triﬂate (Ph3PAuOTf) derivative is a more
dissociated complex with increased electrophilicity at the gold
center. The air stable Ph3PAuOTf was generated in situ from tri-
phenylphosphine gold(I) chloride and silver triﬂuoromethanesul-
fonate (both 5 mol %), in dichloromethane, at room temperature,
and facilitated almost quantitative conversion of 2a into furan 7a
(Table 3, entry 6).
Lowering the Ph3PAuOTf catalyst load to 1 mol % was inef-
fective due to slow conversion (Table 3, entries 7–9). In further
efforts to reduce the amount of gold/silver catalytic system
increase of enolization was sought by an addition of a co-catalyst
that would be compatible with the gold triﬂate acting species.55
In order to maintain the presence of the counterion, zinc triﬂate
seemed to be a logical choice. When Ph3PAuOTf (1 mol%) was
combined with Zn(OTf)2 (5 mol%, DCM, rt) and ﬂuorobuty-
none 2a, the quantitative formation of ﬂuorofuran 7a was
conﬁrmed by 19F NMR. The reaction required 2 h for com-
pletion (Table 3, entry 10). The same reaction time and concen-
tration with 1 mol% Ph3PAuOTf gave only 8% of the
ﬂuorofuran 7a (Table 3, entry 7). The control experiment using
only Zn(OTf)2 (20 mol%, 12 h) showed no conversion of 2a
(Table 3, entry 11). To clarify the role of the counterion, the reac-
tion was carried out with 5 mol% Ph3PAuBF4, and full conver-
sion was observed (Table 3, entry 12). Thus, it can be concluded
that the catalytic system does not depend signiﬁcantly on the
counterion.56 It is in line with the report that the non-triﬂate
system Ph3PAuCl/Zn(ClO4)2 is as well an effective catalyst.
55
Preparation of alk-3-yn-1-ones (propargyl ketones), the
necessary starting materials, was carried out as described
earlier.24,57 Although we focused on aryl substituents, we also
examined compounds containing one alkyl, and one cycloalkyl
group. The explored substituents of silyl enol ethers 6 include
aryl, ethyl, cyclopropyl, and phenoxymethyl; detailed structures
are provided in Table 1.
Due to the gradual decomposition of the monoﬂuoroketones
during storage in solution and our inability to establish an effec-
tive puriﬁcation procedure (especially for 2g and 2h), a sequence
of consecutive ﬂuorination and cyclization reactions, starting
from silyl enol ethers 6 and proceeding in the same ﬂask,
without isolation of 2-ﬂuoroalkynones 2 (Scheme 5) was used
for preparative purposes (Table 4). Unfortunately attempted
ﬂuorination of silyl ether 6h gave a complex reaction mixture at
both rt and 0 °C.58 Hence no cyclization reactions with the use
of this compound were pursued.
The electron withdrawing effect of ﬂuorine signiﬁcantly inhi-
bits not only the cycloisomerization process of ﬂuorinated alky-
nones, but the halocyclization as well. To ﬁne-tune the catalytic
system, optimization was carried out for the bromocyclization
reaction, using ﬂuoroketone 2a as a model compound. The
better stability of formed bromofuran towards gold catalyst along
with the milder halogenation reagent (NBS) provided an advan-
tage over the initial optimization results acquired for the iodocy-
clization reaction.25 The bromination reactions were cleaner;
essentially since only the product and unreacted substrate were
observed.
Scheme 4 Synthesis of 2-ﬂuorobutynone 2a.
Table 3 Catalyst optimization: cycloisomerization of ﬂuorobutynone 2a
Entry Catalyst Loading [mol %] Solvent Conditions Yield [%]
1 ZnCl2 100 DCM reﬂux, 3 h no reaction
2 AgNO3 10 acetone rt, 4 h no reaction
3 (PhCN)2PdCl2 10 DCM rt, 1 h 60
a
4 AuCl3 5 acetonitrile rt, 30 min nd
c
5 AuCl 5 DCM rt, 2 h no reaction
6 Ph3PAuCl/AgOTf 5 DCM rt, 10 min 95
a
7 Ph3PAuCl/AgOTf 1 DCM rt, 10 min trace
8 Ph3PAuCl/AgOTf 1 DCM rt, 2 h 8
b
9 Ph3PAuCl/AgOTf 1 DCM rt, 12 h 42
a,c
10 Ph3PAuCl/AgOTf + Zn(OTf)2 1 + 5 DCM rt, 2 h >98
b
11 Zn(OTf)2 20 DCM rt, 12 h no reaction
b
12 Ph3PAuCl/AgBF4 5 DCM rt, 10 min >98
b
a Isolated product. bConversion determined by 19F NMR. cNot determined, multiple products observed.
2398 | Org. Biomol. Chem., 2012, 10, 2395–2408 This journal is © The Royal Society of Chemistry 2012
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Bromofurans, as compared to iodo derivatives, are less reac-
tive. Therefore, it was projected that side products would orig-
inate from different reaction pathways of the substrate than from
the follow-up reaction involving the product. As anticipated, side
products were less abundant for bromocyclization process.
Efforts for catalytic system optimization are summarized in
Table 5. The reaction with only NBS (1.2 equiv) gave meager
conversion after 10 min (Table 5, entry 1). The addition of
gold(I) chloride (5 mol%) accelerated the reaction in a minor
way (Table 5, entries 2 and 3). Bromocyclization in the presence
of ZnBr2 (20 mol%) was more effective, with a 43% conversion
after 10 min and almost quantitative conversion after prolonged
time, or with the use of larger amount of the catalyst (Table 5,
entries 4–7). We were delighted to notice that a combination of
gold(I) chloride (5 mol%) and ZnBr2 (20 mol%) gave almost
quantitative conversion within 10 min (entry 8).
Separation of halofurans from regular furans that could poten-
tially form during the reaction as side or competing products are
difﬁcult to achieve by silica gel column chromatography due to
overlapping Rf values. To our delight, we did not observe by
1H
NMR formation of the non-halogenated ﬂuorofurans 7 in the
halocyclizations post reaction mixtures, which spared a poten-
tially tedious separation of H-furans from halofurans and facili-
tated reasonable yields (Table 4).
The molecular structure of a dihalofuran was conﬁrmed by
X-ray crystallography. Crystallization of compound 8a from
ether gave single crystals suitable for X-ray analysis. Inspection
of Fig. 2 conﬁrms the regiochemistry and reveals the molecular
structure of the expected 3-bromo-4-ﬂuorofuran. No signiﬁcant
distortion of the furan ring due to the presence of ﬂuorine was
noticed. The entire molecule of 8a is nearly planar within
0.12 Å. The maximum atom deviation from the average plane is
0.25 Å for C-16 and C-18.
The gold-catalyzed formation of furans from propargyl
ketones is believed to proceed via an intramolecular, stepwise
mechanism (Fig. 3). Since non-terminal alkynes were used in
this work, the mechanistic pathway can be illustrated using the
coordination of Au to the carbon–carbon triple bond. The role of
zinc is not conﬁrmed at this moment. Although some zinc
halides are excellent catalysts for the cycloisomerization of
regular alkynones 3,24 the ﬂuoroalkynones 2 are reluctant to
proceed under the sole inﬂuence of zinc bromide or triﬂate. The
inability of zinc to act on its own as a cyclization catalyst may
indicate poor π-bond activation. We believe that the role of zinc,
is to increase enolization of alkynones via coordination to the
oxygen atom of a carbonyl group. In electrophilic cyclization
another role of the zinc halide would be to accelerate the release
of electrophile by enhancement of the dissociation of N-halosuc-
cinimide (NXS) into an electrophilic halogen and/or activation
of the halogen towards an electrophilic reaction.
Scheme 5 Synthesis of ﬂuorofurans 7, 8, and 9 via sequence of ﬂuori-
nation/cyclization.
Table 4 Preparation of ﬂuorofurans 7–9a
Silyl ether 6
Furan 7
yield [%]
Bromofuran 8
yield [%]
Iodofuran 9
yield [%]
a 9523,59 76 6225
b 92 70 78
c 96 68 72
d 94 69 68
e 92 63 65
f 89 — 38
g 52 — —
a For R, R′ see Table 1.
Table 5 Catalyst optimization: bromocyclization of 2-ﬂuorobutynone
2aa
Entry AuCl [%] ZnBr2 [%] Time
b Yieldc
1 — — 10 min 10
2 5 — 10 min 16
3 5 — 1 h 19
4 — 20 10 min 43
5 — 20 15 min 47
6 — 20 11 hd >98
7 — 100 10 min 97e
8 5 20 10 min >98
aNBS (1.2 equiv), DCM, rt, reaction in 0.05 mmol scale, 0.0025 M.
b Solvent evaporation time not accounted for. cConversion determined
by the 19F NMR. d The reaction was not monitored throughout the
interval. eComplete conversion, product accompanied by an unidentiﬁed
compound at δ −103.0 ppm (3%, 19F NMR).
Fig. 2 An ORTEP view of 8a illustrating the atom labeling scheme
and thermal ellipsoids (50% probability level). Selected interatomic dis-
tances (Å): F1–C3 1.392(3), Br1–C4 1.877(3), O1–C2 1.379(4), O1–C5
1.378(4), C2–C3 1.353(4), C2–C6 1.453(5), C3–C4 1.408(4), C4–C5
1.358(4), C5–C12 1.451(4). Key angles (°): C2–O1–C5 109.0(2), O1–
C2–C3 107.0(3), O1–C2–C6 117.5(3), C3–C2–C6 135.5(3), C2–C3–C4
109.0(3), F1–C3–C2 127.1(3), F1–C3–C4 123.9(3), C3–C4–C5 106.9
(3), Br1–C4–C3 123.2(2), Br1–C4–C5 129.8(2), O1–C5–C4 108.1(3),
O1–C5–C12 115.4(3), C4–C5–C12 136.5(3).
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 2395–2408 | 2399
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Electrophilic pathways are believed to proceed via halogen
coordination to the triple bond, which could compete with a
gold-activated cyclization via π-bond activation (Fig. 3). As
mentioned earlier, gold(I) complexes are known to be effective
π-electrophilic Lewis acids.54 Thus the mechanism might
include the formation of the intermediate vinylgold species that
is subsequently trapped by electrophilic halogens. The presence
of zinc might also accelerate protonation/halogenation of such an
intermediate. However, the incidence of the reaction (albeit
slow) with sole N-iodo- or N-bromosuccinimide, indicates that
the electrophilic halogen is capable of acting by itself (Table 5
entry 1 and ref. 25). Also, the lack of non-halogenated ﬂuorofur-
ans formation (within detection limit of 1H NMR), when the
cyclization reaction was carried out in the presence of gold/NXS,
may suggest that gold may not act as the cyclization catalyst but
rather as the activator of the NXS.60 It could also be assumed
that the gold/electrophilic pathways may be parallel to each
other, with presumably the electrophilic cyclization proceeding
faster.
Also, a control experiment was conducted to acquire insight
into the participation of a direct iodination reaction of the
cyclized product in the mechanistic process. A non-halogenated,
3-ﬂuorofuran 7a was treated with NIS (1.2 equiv) in the presence
of AuCl/ZnBr2 (5 : 20 mol%, DCM, rt). After 12 h, no iodofuran
7a was detected in the reaction mixture by GC/MS.
The iodine in furan 9a was utilized to prepare an entirely
diverse substituted β-ﬂuorofurans using cross-coupling reactions.
The Sonogashira coupling of 9a gave phenylethynyl ﬂuorofuran
10 with 92% yield (Scheme 6). The Suzuki–Miyaura coupling
reaction with the thiophene-3-boronic acid was conﬁrmed using
classical conditions to produce thiophenylﬂuorofuran 11 with
92% yield. Lithium N-heterocyclic trialkylborates (trialkoxybo-
rates) were introduced shortly before to facilitate the coupling of
electron-deﬁcient 2-substituted nitrogen-containing hetero-
cycles.61 These organoboron salts, which are commercially avail-
able, provide convenience in handling and use. Applying Cu(I)
enhanced the coupling reaction conditions,62,63 the use of
lithium (pyridin-2-yl)triisopropoxyborate allowed for the intro-
duction of a conventionally unreactive moiety (Scheme 6).
Pyridinyl-substituted ﬂuorofuran 12 was obtained in 85% yields.
The coupling with disulfane (diphenyl disulﬁde), carried out in
reductive conditions,64 produced phenylthio furan 13 with poor
yield (34%). All the couplings required elevated temperature that
was effected by microwaves assistance. The established con-
ditions (80–110 °C, 1–4 h) are comparable to the coupling of
other β-iodofurans (90 °C, 24 h or 110 °C, 0.5–2 h).7,9
Phenylalkynyl ﬂuorofuran 10 gave crystals suitable for study
by X-ray diffraction, which conﬁrmed the structure (Fig. 4). The
crystal structure of 10 shows molecules with nearly planar con-
formations within 0.40 Å. The maximum atom deviations from
Fig. 3 Mechanistic outline for cyclization of alkynones 2 (electrophile/
ketone pathway omitted).
Fig. 4 An ORTEP view of the 10 illustrating atom labeling scheme
and thermal ellipsoids (50% probability level). Selected interatomic dis-
tances (Å): F1–C3 1.3448(19), O1–C2 1.378(2), O1–C5 1.371(2), C2–
C3 1.351(2), C2–C6 1.450(2), C3–C4 1.415(3), C4–C5 1.379(2), C4–
C19 1.423(2), C5–C12 1.454(2), C19–C20 1.198(2), C20–C21 1.436
(2). Key angles (°): C2–O1–C5 108.52(13), O1–C2–C3 107.18(14),
O1–C2–C6 118.09(14), C3–C2–C6 134.73(16), C2–C3–C4 110.13(15),
F1–C3–C2 125.96(16), F1–C3–C4 123.91(15), C3–C4–C5 104.71(15),
C3–C4–C19 125.91(16), C5–C4–C19 129.38(17), O1–C5–C4 109.46
(15), O1–C5–C12 116.19(14), C4–C5–C12 134.35(16), C4–C19–C20
177.8(2), C19–C20–C21 178.0(2).
Scheme 6 Cross-coupling reactions of 3-ﬂuoro-4-iodofuran 9a.
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the average plane are 0.10 and 0.11 Å for C-23 and C-26,
respectively.
New 3-ﬂuorofurans 7–13 (Table 4) were characterized by 1H,
13C, and 19F NMR, IR, (HR)MS. The characteristic 1H NMR
features for ﬂuorofurans 7a–g include the H-4 signals (doublets
7.08–6.28 ppm with JHF 0.7–1.2 Hz). C–F carbons gave rise in
13C NMR to doublets 153.1–150.2, JCF 243.4–255.6 Hz for
ﬂuorofurans 7 and 149.2–148.0/152.2–150.8 ppm (JCF
252.0–253.4/250.1–251.7 Hz) for bromo/iodofurans 8/9, respect-
ively. Longer range couplings, including 4JCF, were observed.
19
The neighboring β-carbons (δ 100.0–99.0/89.9–89.6/
57.4–56.9 ppm) showed 2JCF 20.1–20.6/21.3–21.6/24.8–25.1 Hz
for 7/8/9, respectively. Observed 19F NMR signals for atoms
attached to the furan ring were in a close range (163.0–158.9,
163.8–160.8, 159.0–155.3 ppm, 7/8/9). Mass spectra for 7–13
exhibited intense molecular ion peaks and appropriate isotopic
patterns. Accurate elemental analyses and/or HRMS spectra were
obtained.
Conclusion
In summary, we have demonstrated that Z-butenynyl silyl ethers
6 can be successfully accessed from butynones 3, and their
monoﬂuorination with Selectﬂuor leads to 2-ﬂuorobutynones 2.
Furthermore, 2-ﬂuorobutynones 2 undergo cycloisomerization in
the presence of chlorotriphenylphosphine gold/silver triﬂuoro-
methanesulfonate and halocyclization becomes effective when
N-halosuccinmides are used in combination with gold(I) chlor-
ide/zinc bromide. The synthetic method proved to be best suited
for aryl substituents at α- (C-2 and C-5) furan positions. This
way 3-ﬂuoro-, 3,4-bromoﬂuoro-, and 3,4-ﬂuoroiodofurans 7, 8,
and 9 were obtained with good yields and characterized. The
relatively short reaction times (10 min) and mild conditions (rt)
provide an appealing alternative to the currently available
methods, also from the standpoint of halogen atom economy.
These methods avoid the loss of halogens in the synthetic
pathway, facilitate the regioselective introduction of ﬂuorine
within two available β positions, and also allows for the intro-
duction of substituents such as cycloalkyls that are not easily
carried out by other methods. However, due to the stability of
aryl substituted alkynones the method is best suited for com-
pounds with aryl substituents. The dual catalyst methodology
proves the mild Lewis acid aids the cyclization catalyzed by the
gold catalyst. Additionally, diﬂuorobutynones 4 were prepared
by direct ﬂuorination of ketones 3.
Experimental section
General experimental details
Dichloromethane was collected from the Innovative Technology
PS-MD-6 solvent puriﬁcation system. N-bromosuccinimide
(Avocado) was recrystallized from water. Other reagents were
used as received. Column chromatography was carried out on
silica gel (Dynamic Adsorbents, 32-63 μ). The NMR chemical
shifts are reported: 1H (400 MHz) and 13C (101 MHz) relative to
CDCl3/acetone-d6, 7.26/2.05 ppm and 77.16/29.9 ppm respect-
ively, and 19F (376 MHz) relative to CFCl3 as external standard.
The microwave reactions were carried out using capped vials in
a Biotage Initiator reactor equipped with a conventional tempera-
ture IR sensor.
2,2-Diﬂuoro-4-(4-methylphenyl)-1-phenyl-but-3-yn-1-one (4a)
An oven-dried round-bottom ﬂask was charged with 3a
(0.070 g, 0.30 mmol), L-proline (6.9 mg, 0.060 mmol), Selec-
tﬂuor (0.250 g, 0.700 mmol), and ground 5 Å molecular sieves
(0.50 g). Anhydrous acetonitrile (6 mL) was injected through the
septum. The reaction was stirred at ambient temperature under
nitrogen and monitored by 19F NMR. The reaction was judged
to be complete after 7 days, when mono-ﬂuorinated ketone only
existed in trace amounts. The mixture was diluted with ether
(∼60 mL) and ﬁltered through a Bücher funnel. The ﬁlter cake
was washed with ether (20 mL). The combined ﬁltrate was
stirred with 1 N HCl (10 mL) for 1 h. The organic layer was sep-
arated, dried over MgSO4, ﬁltered and concentrated. Silica gel
chromatography (hexane/ethyl acetate 30 : 1) gave 4a as a yellow
oil (0.051 g, 0.19 mmol, 63%). IR (ν, cm−1, ﬁlm) 2925, 1734,
1718, 1653, 1559. HRMS (DART-TOF) [M + H]+ calcd for
C17H13F2O 271.0935. Found 271.0929. NMR (CDCl3, δ, ppm):
1H 8.23 (d, J = 8.3 Hz, 2H), 7.70–7.64 (m, 1H), 7.58–7.50 (m,
2H), 7.38 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 2.37 (s,
3H); 13C 184.9 (t, J = 30.7 Hz), 134.8, 133.2, 132.4 (t, J = 2.5
Hz), 130.6 (t, J = 2.0 Hz), 129.5, 128.9, 125.7, 116.5 (t, J = 2.9
Hz), 108.4 (t, J = 243.7 Hz), 93.4 (t, J = 6.8 Hz), 79.1 (t, J =
38.2 Hz), 21.9; 19F −88.0.
1-(4-Bromophenyl)-4-(4-(tert-butyl)phenyl)-2,2-diﬂuorobut-3-yn-
1-one (4e)
Procedure analogous to 4a: From 3e (0.107 g, 0.300 mmol); 4e
was obtained as a yellow solid (0.078 g, 0.20 mmol, 67%). IR
(ν, cm−1, ﬁlm) 2925, 2234, 1718, 1653, 1559. HRMS
(DART-TOF) Calcd for [M + H]+ C20H18BrF2O 391.0509.
Found 391.0522. NMR (CDCl3, δ, ppm):
1H 8.09 (AA′XX′, J ≈
8.7 Hz, 2H),65 7.68 (AA′XX′, J ≈ 8.7 Hz, 2H),65 7.42 (AA′XX′,
J ≈ 8.3 Hz, 2H),65 7.38 (AA′XX′, J ≈ 8.3 Hz, 2H),65 1.31 (s,
9H); 13C 184.0 (t, J = 30.8 Hz), 154.6, 132.4, 132.3 (t, J = 2.4
Hz), 132.0 (t, J = 2.0 Hz), 130.5, 130.0, 125.9, 116.3 (t, J = 2.9
Hz), 108.2 (t, J = 244.0 Hz), 93.8 (t, J = 6.6 Hz), 78.8 (t, J =
38.2 Hz), 35.3, 31.3; 19F −88.2.
Preparation of silyl ethers (6)
Procedures A and B. The ﬂask was charged with homopro-
pargyl alcohol 5a (1.42 g, 6.00 mmol) and acetone (30 mL).
Jones reagent (3.0 M, 3.0 mL, 9.0 mmol) was added at 0 °C
(water/ice bath). The reaction was stirred for 20 min at ambient
temperature, quenched with iPrOH (2.0 mL), and concentrated
under vacuum. The residue was diluted with ether (100 mL) and
ﬁltered through a Büchner funnel. The ﬁlter cake was rinsed
with ether (2 × 20 mL). The combined organic solutions were
washed with brine (20 mL), 5% NaHCO3 (20 mL), dried over
MgSO4, and concentrated to yield the ketone 3a as a yellow
solid which was used for the next step without further puriﬁ-
cation. The ﬂask containing the crude ketone 3a was charged
with anhydrous THF (30 mL) under nitrogen. LDA (2.0 M,
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 2395–2408 | 2401
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3.6 mL, 7.2 mmol) was added dropwise at −78 °C and the reac-
tion was stirred for 20 min followed by addition (for procedure
B only) of anhydrous TMEDA (1.80 mL, 12.0 mmol). The reac-
tion was stirred at −78 °C for 10 min and TBSCl (1.08 g,
7.20 mmol) in anhydrous THF (30 mL) was injected in small
portions. The reaction was stirred at ambient temperature for
12 h. After concentration under vacuum, silica gel column
chromatography (hexane/ethyl acetate 50 : 1) gave silyl ether 6a
as a white solid (1.23 g, 3.53 mmol, 60%).
Procedure C. To the homopropargyl alcohol 5b (1.12 g,
6.00 mmol) in acetone (30 mL) Jones reagent (3.0 M, 3.0 mL,
9.0 mmol) was added at 0 °C. The reaction was stirred for
20 min at ambient temperature. The reaction was quenched with
iPrOH (2 mL) and concentrated under vacuum. The residue was
diluted with ether (80 mL) and ﬁltered through a Büchner
funnel. The ﬁlter cake was rinsed with ether (2 × 20 mL). The
combined organic solutions were washed with brine (20 mL)
and 5% NaHCO3 (20 mL). The ﬁltrate was dried over MgSO4,
ﬁltered and concentrated to yield the propargyl ketone as a
yellow oil, which was used for the next step without further
puriﬁcation. The ﬂask containing the propargyl ketone was
charged with NaI (0.300 g, 2.00 mmol) and TBSCl (0.990 g,
6.60 mmol in glovebox). Anhydrous acetonitrile (30 mL) was
injected through the septum. To the above homogeneous solution
DBU (0.99 mL, 6.6 mmol) was added dropwise at 0 °C (water/
ice bath). The reaction mixture was stirred at 0 °C for 4 h (TLC).
After concentration under vacuum, silica gel column chromato-
graphy (hexane) gave 6b as a yellow oil (1.07 g, 3.58 mmol,
60%).
tert-Butyldimethyl{[4-(4-methylphenyl)-1-phenylbut-1-en-3-
yn-1-yl]oxy}silane (6a). Procedure B. Obtained 6a as a white
solid, a mixture of E/Z isomers in a 13 : 87 ratio.46 Calcd for
C23H28OSi: C, 79.26; H, 8.10. Found: C, 79.45; H, 8.51. IR (ν,
cm−1, KBr) 2927, 2856, 2186, 1349, 1103, 816, 787, 765, 694.
UV-vis (ε, M−1cm−1; ether; 3.6 × 10−5 M) 227 (17 000),
314 (28 000). MS (EI, m/z): 348 (30%, M+), 291 (100%,
[M − tBu]+). NMR (CDCl3, δ, ppm): 1H 8.04–7.99 (m, 0.28H),
7.58–7.52 (m, 1.72H), 7.42–7.31 (m, 5H), 7.16–7.09 (m, 2H),
5.59 (s, 0.86H, Z-isomer), 5.38 (s, 0.14H, E-isomer), 2.36 (s,
2.58H), 2.35 (s, 0.42H), 1.03 (s, 7.74H, Z-isomer), 1.00 (s,
1.26H, E-isomer), 0.21 (s, 0.84H, E-isomer), 0.17 (s, 5.16H,
Z-isomer); 13C{1H}(signals for Z-isomer) 160.0, 138.2, 138.0,
131.3, 129.3, 129.0, 128.4, 126.0, 121.4, 94.4, 91.0, 86.8, 26.1,
21.7, 18.8, −3.6.
tert-Butyl[(4-cyclopropyl-1-phenylbut-1-en-3-yn-1-yl)oxy]
dimethylsilane (6b). Procedure C. Obtained 6b as a yellow oil, a
mixture of E/Z isomers in a 8 : 92 ratio.46 Calcd for C19H26OSi:
C, 76.45; H, 8.78. Found: C, 76.27; H, 8.70. IR (ν, cm−1, ﬁlm)
2930, 2858, 2217, 1339, 1257, 1088, 841, 783, 763, 695. MS
(EI, m/z): 298 (20%, M+), 241 (100%, [M − t-Bu]+). NMR
(CDCl3, δ, ppm):
1H 7.52–7.43 (m, 2H), 7.34–7.28 (m, 3H),
5.31 (d, J = 1.8 Hz, 0.92H, Z-isomer), 5.14 (d, J = 2.0 Hz,
0.08H, E-isomer), 1.49–1.34 (m, 1H), 1.01 (s, 8.30H, Z-isomer),
0.97 (s, 0.70H, E-isomer), 0.86–0.74 (m, 4H), 0.16 (s, 0.51H,
E-isomer), 0.13 (s, 5.49H, Z-isomer); 13C{1H}(signals for
Z-isomer) 159.6, 138.3, 128.8, 128.3, 125.8, 98.2, 91.1, 73.5,
26.0, 18.7, 8.5, 0.90, −3.6.
tert-Butyl({[1-(4-ﬂuorophenyl)-4-(4-methylphenyl)but-1-en-3-
yn-1-yl]oxy})dimethylsilane (6c). Procedure C. From 5c (1.52 g,
6.00 mmol). Obtained 6c (1.14 g, 3.12 mmol, 52%) as a white
solid, a mixture of E/Z isomers in a 2 : 98 ratio.46 Calcd for
C23H27FOSi: C, 75.37; H, 7.42. Found: C, 75.55; H, 7.57. IR (ν,
cm−1, KBr) 2955, 2856, 2189, 1506, 1104, 816, 784. UV-vis (ε,
M−1cm−1; ether; 3.7 × 10−5 M) 226 (16 000), 313 (29 000). MS
(EI, m/z): 366 (30%, M+), 309 (100%, M+ − tBu). NMR
(CDCl3, δ, ppm):
1H 7.56–7.50 (m, 2H), 7.35 (dt, J = 8.1, 1.6
Hz, 2H), 7.13 (d, J = 8.1 Hz, 2H), 7.07–7.00 (m, 2H), 5.52 (s,
0.98H, Z-isomer), 5.31 (s, 0.02H, E-isomer), 2.36 (s, 3H), 1.02
(s, 9H), 0.21/0.17 Z/E (s, 6H); 13C{1H}(signals for Z-isomer)
163.3 (d, J = 248.6 Hz), 159.0, 138.0, 134.4 (d, J = 3.2 Hz),
131.3, 129.3, 127.7 (d, J = 8.3 Hz), 121.3, 115.4 (d, J = 21.7
Hz), 94.4, 90.8, 86.6, 26.0, 21.7, 18.7, −3.5.
{[1-(4-Bromophenyl)-4-(4-methylphenyl)but-1-en-3-yn-1-yl]
oxy}(tert-butyl)dimethylsilane (6d). Procedure B. From 5d
(1.88 g, 6.00 mmol). Obtained 6d (1.58 g, 3.70 mmol, 62%) as
a white solid, a mixture of E/Z isomers in a 2 : 98 ratio.46 Calcd
for C23H27BrOSi: C, 64.63; H, 6.37. Found: C, 64.88; H, 6.40.
IR (ν, cm−1, KBr) 2927, 2858, 1484, 894, 784. UV-vis (ε,
M−1cm−1; ether; 3.2 × 10−5 M) 230 (17 000), 319 (37000). MS
(EI, m/z): 426 (20%, M+), 369 (100%, M+ − tBu). NMR
(CDCl3, δ, ppm):
1H 7.48 (dt, J = 8.8, 2.0 Hz, 2H), 7.41 (dt, J =
8.8, 2.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz,
2H), 5.58 (s, 0.98H, Z-isomer), 5.39 (s, 0.02H, E-isomer), 2.36
(s, 3H), 1.02 (s, 8.82H, Z-isomer), 0.99 (s, 0.18H, E-isomer),
0.21 (s, 0.12H, E-isomer), 0.18 (s, 5.88H, Z-isomer); 13C{1H}
(signals for Z-isomer) 158.8, 138.2, 137.1, 131.6, 131.3, 129.3,
127.4, 123.1, 121.2, 94.9, 91.5, 86.5, 26.0, 21.7, 18.7, −3.5.
{[1-(4-Bromophenyl)-4-(4-tert-butylphenyl)but-1-en-3-yn-1-yl]
oxy}(tert-butyl)dimethylsilane (6e). Procedure B. From 5e
(2.14 g, 6.00 mmol). Obtained 6e (1.92 g, 4.08 mmol, 68%) as a
white solid, a mixture of E/Z isomers in a 6 : 94 ratio.46 Calcd
for C26H33BrOSi: C, 66.51; H, 7.08. Found: C, 66.61; H, 7.08.
IR (ν, cm−1, KBr) 2929, 2855, 2195, 1252, 1093, 1009, 894,
835, 784. UV-vis (ε, M−1cm−1; ether; 3.2 × 10−5 M) 228
(20 000) sh, 320 (37 000). MS (EI, m/z): 470 (20%, M+), 413
(100%, M+ − tBu). NMR (CDCl3, δ, ppm): 1H 7.54–7.31 (m,
8H), 5.59 (s, 0.94H, Z-isomer), 5.40 (s, 0.06H, E-isomer), 1.33
(s, 9H), 1.03 (s, 8.46H, Z-isomer), 0.99 (s, 0.54H, E-isomer),
0.21 (s, 0.36H, E-isomer), 0.19 (s, 5.64H, Z-isomer); 13C{1H}
(signals for Z-isomer) 158.7, 151.3, 137.2, 131.6, 131.1, 127.4,
125.5, 123.1, 121.2, 95.0, 91.6, 86.5, 35.0, 31.4, 26.0, 18.7,
−3.5.
tert-Butyldimethyl{[4-(4-methylphenyl)-1-[4-(triﬂuoromethyl)
phenyl]but-1-en-3-yn-1-yl]oxy}silane (6f). Procedure B. From 5f
(0.610 g, 2.00 mmol). Obtained 6f (0.510 g, 1.22 mmol, 61%)
as a white solid, a mixture of E/Z isomers in a 3 : 97 ratio.46
Calcd for C24H27F3OSi: C, 69.20; H, 6.53. Found: C, 69.43; H,
6.67. IR (ν, cm−1, KBr) 2930, 1323, 1125, 1068, 814, 781. UV-
vis (ε, M−1cm−1; ether; 3.3 × 10−5 M) 225 (20 000), 323
(29 000). MS (EI, m/z): 416 (10%, M+), 359 (100%, M+ − tBu).
NMR (CDCl3, δ, ppm):
1H 7.66 (d, J = 8.4 Hz, 2H), 7.61 (d, J =
8.4 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H),
5.68 (s, 0.97H, Z-isomer), 5.48 (s, 0.03H, E-isomer), 2.37 (s,
3H), 1.03 (s, 8.73H, Z-isomer), 1.00 (s, 0.27H, E-isomer), 0.23
2402 | Org. Biomol. Chem., 2012, 10, 2395–2408 This journal is © The Royal Society of Chemistry 2012
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(s, 0.18H, E-isomer), 0.19 (s, 5.82H, Z-isomer); 13C{1H}(signals
for Z-isomer) 158.2, 141.6, 138.4, 131.4, 130.8 (q, J = 32.5 Hz),
129.4, 126.0, 125.5 (q, J = 3.8 Hz), 124.3 (q, J = 271.8 Hz),
121.0, 95.6, 92.9, 86.2, 26.0, 21.7, 18.7, −3.5.
tert-Butyldimethyl[(6-phenylhex-3-en-5-yn-3-yl)oxy]silane (6g).
Procedure A. From 5g (1.05 g, 6.03 mmol). Silica gel was
washed with 1% Et3N/eluent (v/v).Obtained 6g (1.18 g,
4.12 mmol, 68%) as a yellow oil, a mixture of E/Z isomers in a
89 : 11 ratio.46 IR (ν, cm−1, ﬁlm) 2931, 2859, 2201, 1594, 1490,
1293, 871, 840. MS (EI, m/z): 286 (10%, M+), 229 (100%, [M
− tBu]+). NMR (CDCl3, δ, ppm): 1H 7.42–7.38 (m, 2H),
7.33–7.24 (m, 3H), 4.93 (s, 0.11 H, Z-isomer), 4.89 (s, 0.89 H,
E-isomer), 2.48 (q, J = 7.5 Hz, 2H), 1.13 (t, J = 7.5 Hz, 3H),
0.96 (s, 9H), 0.22 (s, 6H); 13C 168.4, 131.1, 128.5, 127.4, 124.7,
91.7, 87.5, 87.3, 27.5, 25.8, 18.4, 11.6, −4.3.
tert-Butyldimethyl{[5-(4-methylphenyl)-1-phenoxypent-2-en-
4-yn-2-yl]oxy}silane (6h). Procedure C. From 5h (1.60 g,
6.00 mmol). Obtained 6h (1.26 g, 3.30 mmol, 55%) as a yellow
solid, a mixture of E/Z isomers in a 22 : 78 ratio.46 Calcd for
C24H30O2Si: C, 76.14; H, 7.99. Found: C, 76.08; H, 8.11. IR (ν,
cm−1, KBr) 2929, 2857, 2198, 1378, 1237. MS (EI, m/z): 378
(30%, M+), 229 (100%). NMR (CDCl3, δ, ppm):
1H 7.36–7.29
(m, 4H), 7.12 (d, J = 8.0 Hz, 2H), 7.04–6.91 (m, 3H), 5.32 (s,
0.78H, Z-isomer), 5.23 (s, 0.22H, E-isomer), 4.84 (s, 0.44H, E-
isomer), 4.44 (s, 1.56H, Z-isomer), 2.36 (s, 3H), 1.01 (s, 6.85H,
Z-isomer), 0.93 (s, 2.15H, E-isomer), 0.32 (s, 4.49H, Z-isomer),
0.17 (s, 1.51H, E-isomer); 13C{1H}(signals for Z-isomer) 158.4,
157.0, 138.0, 131.3, 129.8, 129.3, 121.5,121.2, 114.9, 93.3,
90.9, 85.2, 69.1, 25.9, 21.7, 18.6, −3.5.
2-Fluoroalk-3-yn-1-ones (2): general procedure
A 100 mL round-bottom ﬂask was charged with ether 6
(0.500 mmol), Selectﬂuor (0.195 g, 0.550 mmol), and aceto-
nitrile (10 mL). The mixture was stirred at ambient temperature
(22 °C) and monitored by TLC (hexane/EtOAc 8 : 2; usually for
1 h). Solvent was removed by rotary evaporation and the residue
was kept under oil pump vacuum for 30 min. DCM (60 mL) was
added and the mixture was stirred for 10 min. The solid was
ﬁltered off (fritted funnel) and the ﬁlter cake was washed with
DCM (20 mL). Solvent was removed from the combined ﬁltrates
by rotary evaporation to give crude 2.
4-Cyclopropyl-2-ﬂuoro-1-phenylbut-3-yn-1-one (2b). NMR
(CDCl3, δ, ppm):
1H 8.12–8.05 (m, 2H), 7.66–7.60 (m, 1H),
7.54–7.48 (m, 2H), 5.98 (dd, J = 49.5, 2.1 Hz, 1H), 1.35–1.24
(m, 1H), 0.86–0.69 (m, 4H); 19F −177.8 (d, J = 49.5 Hz).
3-Fluorofurans (7): general procedure
Crude 2 (obtained from 6 as described above) was dissolved in
DCM (10 mL). To the solution, Ph3PAuCl (0.013 g,
0.025 mmol) and AgOTf (0.0065 g, 0.025 mmol) were added
and the mixture was stirred vigorously in the dark (the ﬂask was
wrapped in Al foil) for 10 min. The residue was concentrated by
rotary evaporation and puriﬁed by silica gel column chromato-
graphy (hexane).
5-Cyclopropyl-3-ﬂuoro-2-phenylfuran (7b). From 6b
(0.150 g, 0.500 mmol). Obtained 7b (0.092 g, 0.46 mmol, 92%)
as a yellow oil. Calcd for C13H11FO: C, 77.21; H, 5.48. Found:
C, 76.75; H, 6.40. IR (ν, cm−1, neat) 2924, 1653, 1636, 1559,
1457, 1424, 668. MS (EI, m/z): 202 (M+). NMR (δ, ppm): 1H
(acetone-d6) 7.64–7.58 (m, 2H), 7.48–7.40 (m, 2H), 7.29–7.23
(m, 1H), 6.28 (d, J = 0.8 Hz, 1H), 2.04–1.96 (m, 1H), 1.02–0.96
(m, 2H), 0.91–0.85 (m, 2H); 13C (acetone-d6) 156.2 (d, J = 9.0
Hz), 150.7 (d, J = 252.0 Hz), 134.9 (d, J = 20.6 Hz), 130.2 (d,
J = 5.0 Hz), 129.8, 127.6 (d, J = 1.3 Hz), 123.7 (d, J = 5.3 Hz),
99.3 (d, J = 20.2 Hz), 10.1 (d, J = 1.3 Hz), 7.6; 19F (CDCl3)
−163.0.
3-Fluoro-2-(4-ﬂuorophenyl)-5-(4-methylphenyl)furan (7c).
From 6c (0.184 g, 0.500 mmol). Obtained 7c (0.125 g,
0.480 mmol, 96%) as a white solid, mp 100–101 °C. Calcd for
C17H12F2O: C, 75.55; H, 4.48. Found: C, 75.50; H, 4.60. IR (ν,
cm−1, KBr) 2921, 1635, 1507, 1403, 1234, 826, 792. MS (EI,
m/z): 270 (M+). NMR (δ, ppm): 1H (acetone-d6) 7.85–7.78 (m,
2H), 7.77–7.70 (m, 2H), 7.32–7.25 (m, 4H), 7.02 (d, J = 0.84
Hz, 1H), 2.36 (s, 3H); 13C (acetone-d6) 162.7 (dd, J = 245.7, 2.1
Hz), 151.8 (d, J = 9.8 Hz), 151.3 (dd, J = 252.0, 1.7 Hz), 139.4,
135.5 (d, J = 20.8 Hz), 130.5, 128.3 (d, J = 2.1 Hz), 126.4 (dd, J
= 5.2, 3.0 Hz), 126.3 (dd, J = 8.1, 5.3 Hz), 124.7, 116.9 (d, J =
22.1 Hz), 99.7 (d, J = 20.3 Hz), 21.4; 19F (CDCl3) −114.8,
−163.0.
2-(4-Bromophenyl)-3-ﬂuoro-5-(4-methylphenyl)furan (7d).
From 6d (0.214 g, 0.500 mmol). Obtained 7d (0.155 g,
0.468 mmol, 94%) as a white solid, mp 110–112 °C. HRMS
(DART-TOF) Calcd for [M]+ C17H12BrFO: 330.0056. Found:
330.0265. IR (ν, cm−1, KBr) 2923, 1636, 1499, 1395, 824, 790.
MS (EI, m/z): 331 (M+). NMR (δ, ppm): 1H (acetone-d6)
7.76–7.59 (m, 6H), 7.27 (d, J = 7.9 Hz, 2H), 6.98 (d, J = 0.7
Hz, 1H), 2.35 (s, 3H); 13C (acetone-d6) 152.3 (d, J = 9.0 Hz),
152.0 (d, J = 253.7 Hz), 139.6, 135.3 (d, J = 20.6 Hz), 133.0,
130.5, 128.9 (d, J = 4.9 Hz), 128.2 (d, J = 2.1 Hz), 125.9 (d, J =
5.4 Hz), 124.8, 121.2 (d, J = 2.3 Hz), 100.0 (d, J = 20.4 Hz),
21.4; 19F (CDCl3) −160.8.
2-(4-Bromophenyl)-5-(4-tert-butylphenyl)-3-ﬂuorofuran (7e).
From 6e (0.235 g, 0.500 mmol). Obtained 7e (0.172 g,
0.461 mmol, 92%) as a white solid, mp 72–73 °C. Calcd for
C20H18BrFO: C, 64.36; H, 4.86. Found: C, 64.64; H, 4.95. IR
(ν, cm−1, KBr) 2959, 1636, 1395, 831, 820. MS (EI, m/z): 373
(M+). NMR (δ, ppm): 1H (acetone-d6) 7.80–7.74 (m, 2H),
7.73–7.64 (m, 4H), 7.54–7.49 (m, 2H), 7.03 (d, J = 0.8 Hz, 1H),
1.34 (s, 9H); 13C (acetone-d6) 152.7, 152.2 (d, J = 8.8 Hz),
152.0 (d, J = 253.6 Hz), 135.4 (d, J = 20.6 Hz), 133.0, 128.9
(d, J = 5.0 Hz), 128.1 (d, J = 2.1 Hz), 126.8, 125.9 (d, J = 5.4
Hz), 124.7, 121.2 (d, J = 2.3 Hz), 100.0 (d, J = 20.1 Hz), 35.4,
31.6; 19F (CDCl3) −160.7.
3-Fluoro-5-(4-methylphenyl)-2-[4-(triﬂuoromethyl)phenyl]
furan (7f ). From 6f (0.208 g, 0.500 mmol). Obtained 7f
(0.142 g, 0. 444 mmol, 89%) as a white solid, mp 132–133 °C.
Calcd for C18H12F4O: C, 67.50; H, 3.78. Found: C, 67.22; H,
3.67. IR (ν, cm−1, KBr) 2926, 1634, 1410, 1339, 1165, 1108,
1072, 840, 792. MS (EI, m/z): 320 (M+). NMR (δ, ppm): 1H
(acetone-d6) 7.82 (d, J = 8.2 Hz, 2H), 7.97 (d, J = 8.2 Hz, 2H),
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 2395–2408 | 2403
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7.80–7.74 (m, 2H), 7.36–7.28 (m, 2H), 7.08 (d, J = 0.7 Hz, 1H),
2.38 (s, 3H); 13C (acetone-d6) 153.2 (d, J = 8.8 Hz), 153.1 (d,
J = 255.6 Hz), 139.9, 134.9 (d, J = 20.4 Hz), 133.3 (d, J = 3.8
Hz), 130.6, 128.9 (qd, J = 33.3, 1.9 Hz), 128.0 (d, J = 2.2 Hz),
126.9 (q, J = 3.9 Hz), 125.4 (q, J = 271.2 Hz), 125.0, 124.4 (d,
J = 5.5 Hz), 99.9 (d, J = 20.1 Hz), 21.4; 19F (CDCl3) −63.0
(3F), −158.9 (1F).
2-Ethyl-3-ﬂuoro-5-phenylfuran (7g). From 6g (0.143 g,
0.500 mmol). Obtained 7g (0.049 g, 0.26 mmol, 52%) as a col-
orless oil. NMR (acetone-d6, δ, ppm):
1H 7.71–7.64 (m, 2H),
7.45–7.37 (m, 2H), 7.33–7.26 (m, 1H), 6.83 (d, J = 1.2 Hz, 1H),
2.73 (qd, J = 7.6, 1.8 Hz, 2H); 1.27 (t, J = 7.6 Hz, 3H); 13C
150.3 (d, J = 9.2 Hz), 150.2 (d, J = 243.4 Hz), 140.0 (d, J =
25.9 Hz), 131.5 (d, J = 2.1 Hz), 129.7, 128.6, 124.1, 99.0 (d, J =
20.6 Hz), 18.9 (d, J = 3.1 Hz), 12.4 (d, J = 1.7 Hz).
3-Bromo-4-ﬂuorofurans (8) and 3-ﬂuoro-4-iodofurans (9):
general procedure
The ﬂask containing crude 2 (obtained from 6 as described
above) was charged with N-halosuccinimide (NIS 0.135 g,
0.600 mmol or NBS, 0.107 g, 0.600 mmol) and anhydrous
DCM (7.0 mL). The mixture was stirred for a few minutes to
become homogeneous, then anhydrous ground ZnBr2 (0.0225 g,
0.100 mmol) was added followed immediately by AuCl
(0.0058 g, 0.025 mmol) in anhydrous DCM (3.0 mL). The
mixture was stirred vigorously at ambient temperature for
10 min. The reaction was quenched by adding saturated sodium
thiosulfate aqueous solution (10 mL) and stirred for few
minutes. DCM (60 mL) was added. The organic layer was separ-
ated, dried over MgSO4, ﬁltered, and concentrated under reduced
pressure. The product was puriﬁed by silica gel column chrom-
atography (hexane).
3-Bromo-4-ﬂuoro-2-(4-methylphenyl)-5-phenylfuran (8a).
From 6a (0.175 g, 0.500 mmol). Obtained 8a (0.103 g,
0.311 mmol, 62%) as a white solid, mp 75–76 °C. Calcd for
C17H12BrFO: C, 61.65; H, 3.65. Found: C, 61.95; H, 3.82. IR
(ν, cm−1, KBr) 2924, 1636, 1499, 943, 817, 760, 687. MS (EI,
m/z): 330 (100%, M+). NMR (δ, ppm): 1H (acetone-d6)
8.00–7.94 (m, 2H), 7.82–7.75 (m, 2H), 7.57–7.49 (m, 2H),
7.42–7.33 (m, 3H), 2.39 (s, 3H); 13C (acetone-d6) 148.8 (d, J =
252.4 Hz), 147.1 (d, J = 4.4 Hz), 140.2, 136.1 (d, J = 19.0 Hz),
130.4, 130.1, 129.0 (d, J = 1.4 Hz), 128.8 (d, J = 5.0 Hz), 127.4,
126.2, 124.6 (d, J = 5.0 Hz), 89.6 (d, J = 21.5 Hz), 21.4; 19F
(CDCl3) −162.2.
3-Bromo-2-cyclopropyl-4-ﬂuoro-5-phenylfuran (8b). From 6b
(0.150 g, 0.500 mmol). Obtained 8b (0.110 g, 0.391 mmol,
78%) as a white soft solid. IR (ν, cm−1, neat) 2925, 1638, 1497,
1428, 1002, 759. MS (EI, m/z): 280 (100%, M+). HRMS
(DART-TOF) Calcd for [M + H]+ C13H11BrFO 280.9977. Found
280.9978. NMR (δ, ppm): 1H (CDCl3) 7.62–7.55 (m, 2H),
7.43–7.36 (m, 2H), 7.26–7.22 (m, 1H), 2.04–1.94 (m, 1H),
1.09–0.98 (m, 4H); 13C (acetone-d6) 151.8 (d, J = 4.5 Hz),
148.0 (d, J = 252.5 Hz), 134.8 (d, J = 19.7 Hz), 129.9, 129.2 (d,
J = 5.1 Hz), 128.4 (d, J = 1.4 Hz), 124.0 (d, J = 5.1 Hz), 89.9
(d, J = 21.3 Hz), 9.0, 7.3; 19F (CDCl3) −163.8.
3-Bromo-4-ﬂuoro-5-(4-ﬂuorophenyl)-2-(4-methylphenyl)furan
(8c). From 6c (0.183 g, 0.500 mmol). Obtained 8c (0.125 g,
0.358 mmol, 72%) as a white solid, mp 103–105 °C. Calcd for
C17H11BrF2O: C, 58.48; H, 3.18. Found: C, 58.32; H, 3.50. IR
(ν, cm−1, KBr) 2922, 1508, 1406, 1233, 945, 828, 812. MS (EI,
m/z): 348 (100%, M+). NMR (δ, ppm): 1H (acetone-d6) 7.96 (d,
J = 8.3 Hz, 2H), 7.87–7.81 (m, 2H), 7.36 (d, J = 8.2 Hz, 2H),
7.35–7.28 (m, 2H), 2.39 (s, 3H); 13C (acetone-d6) 163.2 (dd, J =
247.2, 2.2 Hz), 148.5 (dd, J = 252.0, 2.2 Hz), 147.2 (d, J = 3.8
Hz), 140.2, 135.4 (d, J = 19.3 Hz), 130.5, 127.3 (d, J = 1.5 Hz),
126.8 (dd, J = 8.5, 5.0 Hz), 126.2, 125.4 (dd, J = 5.1, 3.1 Hz),
117.1 (d, J = 22.4 Hz), 89.6 (d, J = 21.5 Hz), 21.4; 19F (CDCl3)
−163.0, −113.5.
3-Bromo-5-(4-bromophenyl)-4-ﬂuoro-2-(4-methylphenyl)furan
(8d). From 6d (0.214 g, 0.500 mmol). Obtained 8d (0.139 g,
0.339 mmol, 68%) as a white solid, mp 101–103 °C. Calcd for
C17H11Br2FO: C, 49.79; H, 2.70. Found: C, 50.05; H, 2.84. IR
(ν, cm−1, KBr) 2923, 1636, 1488, 1397, 944, 821. MS (EI, m/z):
410 (100%, M+). NMR (δ, ppm): 1H (acetone-d6) 8.00–7.94 (m,
2H), 7.76–7.69 (m, 4H), 7.39–7.34 (m, 2H), 2.40 (s, 3H); 13C
(acetone-d6) 149.2 (d, J = 253.3 Hz), 147.6 (d, J = 4.3 Hz),
140.4, 135.2 (d, J = 19.2 Hz), 133.2, 130.5, 127.9 (d, J = 5.1
Hz), 127.2 (d, J = 1.4 Hz), 126.3 (d, J = 4.9 Hz), 126.3, 122.3
(d, J = 2.2 Hz), 89.7 (d, J = 21.6 Hz), 21.5; 19F (CDCl3)
−160.8.
3-Bromo-5-(4-bromophenyl)-2-(4-tert-butylphenyl)-4-ﬂuor-
ofuran (8e). From 6e (0.235 g, 0.500 mmol). Obtained 8e
(0.148 g, 0.327 mmol, 65%) as a white solid, mp 122–123 °C.
Calcd for C20H17Br2FO: C, 53.13; H, 3.79. Found: C, 53.68; H,
3.85. IR (ν, cm−1, KBr) 2959, 1653, 1636, 832, 817, 668. MS
(EI, m/z): 452 (100%, M+). NMR (δ, ppm): 1H (acetone-d6)
8.04–7.97 (m, 2H), 7.75–7.68 (m, 4H), 7.63–7.56 (m, 2H), 1.38
(s, 9H); 13C (acetone-d6) 153.4, 149.2 (d, J = 253.4 Hz), 147.6
(d, J = 4.3 Hz), 135.2 (d, J = 19.1 Hz), 133.2, 127.9 (d, J = 5.1
Hz), 127.2, 126.7, 126.3 (d, J = 5.1 Hz), 126.2, 122.2 (d, J = 2.1
Hz), 89.8 (d, J = 21.4 Hz), 35.5, 31.5; 19F (CDCl3) −160.8.
2-Cyclopropyl-4-ﬂuoro-3-iodo-5-phenylfuran (9b). From 6b
(0.150 g, 0.500 mmol). Obtained 9b (0.115 g, 0.350 mmol,
70%) as a white solid, mp 61–62 °C. Calcd for C13H10FIO: C,
47.59; H, 3.07. Found: C, 47.55; H, 3.25. IR (ν, cm−1, KBr)
3010, 1636, 1494, 1417, 997, 760. MS (EI, m/z): 328 (100%,
M+). NMR (δ, ppm): 1H (CDCl3) 7.62–7.54 (m, 2H), 7.43–7.36
(m, 2H), 7.26–7.21 (m, 1H), 2.02–1.94 (m, 1H), 1.09–0.97 (m,
4H); 13C (acetone-d6) 154.8 (d, J = 6.1 Hz), 150.8 (d, J = 251.2
Hz), 134.9 (d, J = 21.0 Hz), 129.8, 129.2 (d, J = 5.2 Hz), 128.2,
123.9 (d, J = 5.1 Hz), 57.4 (d, J = 24.8 Hz), 10.3, 7.7; 19F
(CDCl3) −159.0.
3-Fluoro-2-(4-ﬂuorophenyl)-4-iodo-5-(4-methylphenyl)furan
(9c). From 6c (0.183 g, 0.500 mmol). Obtained 9c (0.135 g,
0.341 mmol, 68%) as a white solid, mp 98–99 °C. Calcd for
C17H11F2IO: C, 51.54; H, 2.80. Found: C, 51.94; H, 3.21. IR (ν,
cm−1, KBr) 2919, 1701, 1653, 1508, 837, 817. MS (EI, m/z):
396 (100%, M+). NMR (δ, ppm): 1H (acetone-d6) 8.03–7.97 (m,
2H), 7.85–7.78 (m, 2H), 7.39–7.26 (m, 4H), 2.40 (s, 3H); 13 C
(acetone-d6) 163.1 (dd, J = 246.6, 2.2 Hz), 151.5 (dd, J = 250.1,
2404 | Org. Biomol. Chem., 2012, 10, 2395–2408 This journal is © The Royal Society of Chemistry 2012
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2.2 Hz), 149.7 (d, J = 6.0 Hz), 140.2, 135.5 (d, J = 21.2 Hz),
130.3, 128.0 (d, J = 1.3 Hz), 126.9, 126.7 (dd, J = 8.2, 5.1 Hz),
125.5 (dd, J = 5.1, 3.5 Hz), 117.1 (d, J = 22.2 Hz), 56.9 (d, J =
25.1 Hz), 21.4; 19F (CDCl3) −157.6, −113.7.
2-(4-Bromophenyl)-3-ﬂuoro-4-iodo-5-(4-methylphenyl)furan
(9d). From 6d (0.214 g, 0.500 mmol). Obtained 9d (0.158 g,
0.346 mmol, 69%) as a white solid, mp 104–106 °C. Calcd for
C17H11BrFIO: C, 44.67; H, 2.43. Found: C, 45.12; H, 2.49. IR
(ν, cm−1, KBr) 2920, 1700, 1653, 1559, 940, 824. MS (EI, m/z):
456 (100%, M+). NMR (δ, ppm): 1H (acetone-d6) 8.04–7.99 (m,
2H), 7.75–7.68 (m, 4H), 7.40–7.34 (m, 2H), 2.40 (s, 3H); 13C
(acetone-d6) 152.2 (d, J = 251.5 Hz), 150.2 (d, J = 5.9 Hz),
140.4, 135.3 (d, J = 20.8 Hz), 133.2, 130.3, 128.0 (d, J = 5.4
Hz), 127.9 (d, J = 1.4 Hz), 126.9, 126.3 (d, J = 5.1 Hz), 122.0
(d, J = 2.4 Hz), 57.0 (d, J = 24.9 Hz), 21.4; 19F (CDCl3)
−155.3.
2-(4-Bromophenyl)-5-(4-tert-butylphenyl)-3-ﬂuoro-4-iodofuran
(9e). From 6e (0.235 g, 0.500 mmol). Obtained 9e (0.156 g,
0.313 mmol, 63%) as a white solid, mp 143–144 °C. Calcd for
C20H17BrFIO: C, 48.12; H, 3.43. Found: C, 48.22; H, 3.33. IR
(ν, cm−1, KBr) 2958, 1653, 1559, 1395, 940, 832, 816, 668. MS
(EI, m/z): 498 (100%, M+). NMR (δ, ppm): 1H (acetone-d6)
8.10–8.05 (m, 2H), 7.77–7.69 (m, 4H), 7.64–7.59 (m, 2H), 1.38
(s, 9H); 13C (acetone-d6) 153.4, 152.2 (d, J = 251.7 Hz), 150.2
(d, J = 5.9 Hz), 135.4 (d, J = 21.1 Hz), 133.2, 128.0 (d, J = 5.1
Hz), 127.9 (d, J = 1.5 Hz), 126.8, 126.6, 126.3 (d, J = 5.1 Hz),
122.0 (d, J = 2.2 Hz), 57.1 (d, J = 24.9 Hz), 35.5, 31.5; 19F
(CDCl3) −155.3.
3-Fluoro-4-iodo-5-(4-methylphenyl)-2-[4-(triﬂuoromethyl)
phenyl]furan (9f ). From 6f (0.208 g, 0.500 mmol). Obtained 9f
(0.085 g, 0.19 mmol, 38%) as a white solid, mp 79–81 °C. IR
(ν, cm−1, KBr) 2924, 2853, 1616, 1407, 1326, 1164, 1107,
1070, 839, 816. MS (EI, m/z): 446 (100%, M+). HRMS
(DART-TOF) Calcd for M+ C18H11F4IO: 445.9791. Found:
445.9772. NMR (δ, ppm): 1H (acetone-d6) 8.06–8.00 (m, 2H),
7.97 (d, J = 8.2 Hz, 2H), 7.85 (d, J = 8.3 Hz, 2H), 7.37 (d, J =
8.0 Hz, 2H), 2.40 (s, 3H); 13C (acetone-d6) 153.2 (d, J = 253.5
Hz), 150.9 (d, J = 5.9 Hz), 140.7, 134.9 (d, J = 20.7 Hz), 132.3
(d, J = 5.3 Hz), 130.3, 129.5 (q, J = 32.4 Hz), 127.7 (d, J = 1.3
Hz), 127.0, 127.0 (q, J = 3.9 Hz), 125.3 (q, J = 271.3 Hz), 124.8
(d, J = 5.5 Hz), 57.1 (d, J = 25.0 Hz), 21.4; 19F (CDCl3)
−153.4, −63.1.
3-Fluoro-5-(4-methylphenyl)-2-phenyl-4-(phenylethynyl)furan
(10)
A 10 mL microwave reaction vial was charged with the iodo-
furan 9a (0.095 g, 0.25 mmol), PdCl2(PPh3)2 (0.018 g,
0.025 mmol), and CuI (4.8 mg, 0.025 mmol). The reaction vial
was sealed, then evacuated-backﬁlled with nitrogen (Schlenk
line, three times). Under nitrogen protection, degassed toluene
(5 mL) and Et3N (0.10 mL, 0.75 mmol) were injected into the
vial. Then phenylacetylene (80 μL, 0.73 mmol) was injected to
the reaction. The reaction vial was submitted to microwave
irradiation with stirring (80 °C, 1 h). After 9a had been con-
sumed, as judged by TLC analysis of an aliquot of reaction sol-
ution, the reaction mixture was transferred to a ﬂask with the aid
of ethyl ether (50 mL) and concentrated under vacuum. The
residue was puriﬁed by silica gel ﬂash chromatography
(hexanes) to give 10 as a white solid (0.080 g, 0.23 mmol, 92%),
mp 132–133 °C. IR (ν, cm−1, KBr) 3032, 2919, 2218, 1636,
819, 755, 668. MS (EI, m/z): 352 (100%, M+). HRMS
(DART-TOF) Calcd for [M + H]+ C25H18FO: 353.1342. Found:
353.1330. NMR (CDCl3, δ, ppm):
1H 8.07 (d, J = 8.3 Hz, 2H),
7.82–7.77 (m, 2H), 7.64–7.57 (m, 2H), 7.49–7.38 (m, 5H),
7.34–7.28 (m, 3H), 2.42 (s, 3H); 13C 151.6 (d, J = 4.8 Hz),
149.4 (d, J = 258.9 Hz), 139.1, 135.1 (d, J = 18.6 Hz), 131.8,
129.6, 129.0, 128.9, 128.7, 128.6, 127.7, 127.6 (d, J = 1.5 Hz),
125.0, 123.9 (d, J = 5.1 Hz), 123.2, 97.6 (d, J = 17.4 Hz), 96.9,
78.3 (d, J = 2.5 Hz), 21.7; 19F −161.7.
3-Fluoro-5-(4-methylphenyl)-2-phenyl-4-(thiophen-3-yl)furan
(11)
A 10 mL microwave reaction vial was charged with the iodo-
furan 9a (0.095 g, 0.25 mmol), 3-thiophene-3-boronic acid
(0.064 g, 0.50 mmol), Pd(PPh3)4 (0.029 g, 0.025 mmol), and
Na2CO3 (0.053 g, 0.50 mmol). The reaction vial was sealed,
evacuated and backﬁlled with nitrogen (Schlenk line, three
times). Under nitrogen protection, degassed toluene (5 mL),
EtOH (0.5 mL) and H2O (0.2 mL) were injected into the vial
successively. The reaction vial was submitted to microwave
irradiation with stirring (110 °C, 2 h), and monitored by TLC
analysis of an aliquot of the reaction solution. The reaction
mixture was transferred to a separatory funnel with the aid of
ether (60 mL) and washed with brine (10 mL). The organic layer
was dried over MgSO4, ﬁltered and concentrated under vacuum.
The residue was puriﬁed by silica gel column chromatography
(hexane) to give 11 as a white solid (0.077 g, 0.23 mmol, 92%),
mp 79–81 °C. Calcd for C21H15FOS: C, 75.42; H, 4.52. Found:
C, 75.89; H, 4.88. IR (ν, cm−1, KBr) 2924, 2854, 1495, 1442,
820, 759. MS (EI, m/z): 334 (100%, M+). NMR ( CDCl3, δ,
ppm): 1H 7.83–7.77 (m, 2H), 7.56–7.50 (m, 2H), 7.49–7.42 (m,
3H), 7.39 (dd, J = 5.0, 3.0 Hz, 1H), 7.33–7.28 (m, 1H),
7.21–7.15 (m, 3H), 2.39 (s, 3H); 13C 148.8 (d, J = 255.9 Hz),
146.4 (d, J = 6.0 Hz), 138.6, 135.4 (d, J = 19.6 Hz), 129.6 (d,
J = 2.8 Hz), 129.5 (2C), 129.2 (d, J = 5.0 Hz), 129.0 (2C),
128.2, 127.3, 126.4 (2C), 125.9, 124.2 (d, J = 2.1 Hz), 123.8 (d,
J = 5.2 Hz, 2C), 110.5 (d, J = 16.1 Hz), 21.6;66 19F −164.0.
2-[4-Fluoro-2-(4-methylphenyl)-5-phenylfuran-3-yl]pyridine (12)
A 10 mL microwave reaction vial was charged with the iodo-
furan 9a (0.095 g, 0.25 mmol), lithium (pyridin-2-yl)triisoprox-
yborate (0.110 g, 0.400 mmol), Pd(PPh3)4 (0.029 g,
0.025 mmol), CuCl (0.0025 g, 0.025 mmol), Cs2CO3 (0.098 g,
0.30 mmol), and ZnCl2 (0.034 g, 0.25 mmol, loaded in glove-
box). The reaction vial was sealed, evacuated and backﬁlled with
nitrogen (Schlenk line, three times). Under nitrogen protection,
anhydrous degassed DMF (2 mL) was injected into the vial. The
reaction vial was submitted to microwave irradiation with stirring
(110 °C, 2 h), and monitored by TLC analysis of an aliquot of
reaction solution. After completion, the reaction mixture was
transferred to a ﬂask with the aid of ethyl ether (60 mL) and
washed with brine (10 mL). The organic layer was separated,
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 2395–2408 | 2405
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dried over MgSO4, ﬁltered and concentrated under vacuum. The
residue was puriﬁed by silica gel ﬂash chromatography (hexane/
ethyl acetate 30 : 1) to give 12 as a white solid (0.070 g,
0.22 mmol, 85%), mp 80–82 °C. Calcd for C22H16FNO: C,
80.23; H, 4.90. Found: C, 80.12; H, 5.37. IR (ν, cm−1, KBr)
2920, 1640, 1592, 1416, 816, 763. MS (EI, m/z): 329 (100%,
M+). NMR (CDCl3, δ, ppm):
1H 8.75 (ddd, J = 4.9, 1.8, 0.9 Hz,
1H), 7.85–7.80 (m, 2H), 7.75 (pseudo td J = 7.7, 1.8 Hz, 2H),
7.58–7.53 (m, 2H), 7.52–7.43 (m, 3H), 7.32–7.27 (m, 2H), 7.15
(d, J = 8.0 Hz, 2H), 2.37 (s, 3H); 13C 150.4 (d, J = 3.5 Hz),
150.2, 148.7 (d, J = 257.0 Hz), 147.9 (d, J = 5.7 Hz), 138.8,
136.7, 135.7 (d, J = 19.4 Hz), 129.3, 129.1 (d, J = 4.9 Hz),
129.0, 127.8 (d, J = 1.3 Hz), 127.4 (d, J = 1.0 Hz), 126.6, 125.0
(d, J = 2.0 Hz), 123.9 (d, J = 5.3 Hz), 122.8, 115.1 (d, J = 14.8
Hz), 21.6; 19F −164.5.
3-Fluoro-5-(4-methylphenyl)-2-phenyl-4-(phenylsulfanyl)furan
(13)
A 10 mL microwave reaction vial was charged with the iodo-
furan 9a (0.095 g, 0.25 mmol), diphenyl disulﬁde (0.055 g,
0.25 mmol), PdCl2(dppf ) (0.019 mg, 0.025 mmol), and zinc
dust (0.030 g, 0.50 mmol). The reaction vial was sealed, evacu-
ated and backﬁlled with nitrogen (Schlenk line, three times).
Under nitrogen protection, anhydrous degassed THF (2.5 mL)
was injected into the vial. The reaction vial was submitted to
microwave irradiation with stirring (110 °C, 4 h). The reaction
mixture was ﬁltered through a Bücher funnel with the aid of
ether (60 mL) and the ﬁltrate was washed with brine (10 mL).
The organic layer was dried over MgSO4, ﬁltered and concen-
trated under vacuum. The residue was puriﬁed by silica gel
column chromatography (hexanes) to give 13 as a white soft
solid (0.031 g, 0.086 mmol, 34%). IR (ν, cm−1, KBr) 2924,
1653, 1559. HRMS (DART-TOF) Calcd for [M + H]+
C23H18FOS: 361.1062. Found: 361.1055. NMR (CDCl3, δ,
ppm): 1H 8.01 (d, J = 8.3 Hz, 2H), 7.82–7.75 (m, 2H), 7.46 (t,
J = 7.8 Hz, 2H), 7.33–7.14 (m, 8H), 2.39 (s, 3H); 13C 152.6 (d,
J = 4.5 Hz), 150.4 (d, J = 255.5 Hz), 139.4, 136.5, 136.0, 135.6
(d, J = 19.9 Hz), 129.6 (2C), 129.4 (2C), 129.0 (2C), 127.7,
127.2 (d, J = 1.5 Hz), 127.1 (2C), 126.2, 126.1 (2C), 123.8 (d,
J = 5.1 Hz, 2C), 102.7 (d, J = 20.3 Hz), 21.6; 19F −160.5.
Crystallography
Crystals of 6e (transparent prism, colorless) were grown by evap-
oration of hexanes/ethyl acetate (20 : 1) solution. Crystals of 8a
(transparent needle, colorless) were grown from the ether by
slow evaporation. Crystals of 10 (transparent needle, colorless)
were grown from the pentane by slow evaporation. CCDC
826570, 826571, and 827011, respectively (see the supplemen-
tary crystallographic data for this paper†).
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